Selexipag for pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) after defect correction: insights from the randomized controlled GRIPHON study
Children's University Hospital of Geneva, Geneva (Switzerland)
0
follower
9
more
presentations
in this session
Observer variability in the assessment of congenital coronary abnormalities by invasive and CT coronary angiography: substudy of the anomalous connections of the coronary arteries (ANOCOR) registry